Developing the most revolutionary oncolytic immunotherapeutic candidates
to provide advanced targeted treatments for solid cancer

LATE BREAKING POSTER PRESENTATION FROM THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 2021 ANNUAL MEETING